I

IntoCell Inc

9 employees

Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.

Basic info

Industry

biotechnology research

Sectors

ADC
Biotechnology
Doucarmycin
PBD
Drug Linker Synthesis
Toll Like Receptor Agonist
Medical
Bioconjugation
ISAC
Information Technology

Date founded

2015

Funding rounds raised

Total raised

$900K

from 1 investors over 1 rounds

I

IntoCell Inc raised $900K on January 1, 2016

Investors: stonebridge capital

FAQ